| Biomarker ID | 1115 |
| PMID | 23626811 |
| Year | 2013 |
| Biomarker | Spermine; Putrescine; Cho; PCho; GPC; PE; Lactate; Alanine; Glucose; Citrate; Succinate; Glutamate; Glutamine; Glycine; Isoleucine; Leucine; Valine; |
| Biomarker Basis | Concentration Based (mmol/kg) |
| Biomolecule | Metabolites |
| Source | Tissue |
| Subjects | Humans |
| Regulation | Upregulated in Prostate Cancer [Cho; PCho; GPC; PE; Lactate; Alanine; Glutamate; Glutamine; Glycine; Isoleucine; Leucine; Valine;]; Downregulated in Prostate Cancer: [Spermine; Putrescine; Citrate; Creatine;] |
| Odds Ratio/Hazard Ratio/Relative Risk | NA |
| Effect on Pathways | NA |
| Experiment | Normal adjacent samples Vs Cancer samples |
| Type of Biomarker | Diagnostic |
| Cohort | 47 Normal Prostate Tissue Samples along with 106 Prostate Cancer Samples were selected |
| Senstivity | NA |
| Specificity | NA |
| AUC | NA |
| Accuracy | NA |
| Level Of Significance | p<0.05 |
| Method Used | NA |
| Clinical | No |
| Remarks | NA |
| Clinical Trial Number | NA |
| Degree Of Validity | Not validated on independent patient dataset |
| Technical Name | NA |